Navigation Links
Myriant Technologies LLC Selected for $50 Million Award for Succinic Acid Biorefinery Project
Date:12/7/2009

QUINCY, Mass., Dec. 7 /PRNewswire/ -- Myriant Technologies LLC (as successor to BioEnergy International), a leading biotech developer and manufacturer of renewable biochemicals, has been selected by the U.S. Department of Energy (DOE) to receive up to $50 million for its planned biobased Succinic Acid facility in Louisiana. Notably, among the 19 integrated biorefinery projects that won funding or loan guarantees, Myriant was the only award focused exclusively on biobased chemicals rather than biofuels.

(Logo: http://www.newscom.com/cgi-bin/prnh/20091021/NE96331LOGO )

The DOE and other third-party studies have previously identified biobased Succinic Acid as a priority among the top 12 chemicals by market size that can be derived from biomass. Succinic Acid is used in a wide variety of applications including plastics, fibers, polyesters and pigments.

Myriant's production of biobased Succinic Acid will utilize both local sorghum and carbon dioxide (CO2) to displace petroleum-based feedstocks, using less energy than its petroleum alternative. In addition to the energy savings, by consuming CO2 rather than producing it via oil refining methods, Myriant's process dramatically reduces lifecycle greenhouse gas emissions.

"We are grateful for the validation of our technology embodied in the award by the DOE," said Stephen J. Gatto, Chairman and Chief Executive Officer of Myriant. "We applaud their recognition of the importance of biobased chemicals as a leading component of biorefineries. Our Succinic Acid platform provides a "win-win" solution in terms of cost, environmental benefits and reduction in our dependence on imported oil and puts critical jobs to work right here in the United States."

The award will help fund the construction of Myriant's Succinic Acid plant at the Port of Lake Providence, Louisiana. "The Port and the State of Louisiana have been extraordinary partners, and we expect the site, immediately adjacent to the Mississippi River, to be the foundation of a large biotech corridor in Louisiana," added Mr. Gatto. "We're very excited about bringing this technology and over 250 construction and full time operating jobs to the community."

"The Port of Lake Providence is tremendously excited to be working with Myriant on this very important project," added Wyly Gilfoil, Director of the Lake Providence Port Commission. "We're delighted to see the assets of the Port and the region used in this manner to bring much needed high tech industries and jobs to the community."

About Myriant Technologies

With a world-renowned team of molecular biologists, engineers and chemists, Myriant utilizes proprietary technology to advance the development of low-cost cellulosic sugars for the sustainable manufacturing of high-value specialty chemicals. The company's D(-) lactic acid started production at commercial scale in June 2008 for use in polylactic acid. Myriant will next begin commercial production of its second product, biobased Succinic Acid; samples are currently available by contacting productinfo@myriant.com. Myriant is headquartered in Quincy, Massachusetts. Further information is available at www.myriant.com.


Contact:  Samuel G. McConnell
          Sr. Vice President, Corporate Development
          617-657-5207

SOURCE Myriant Technologies LLC


'/>"/>
SOURCE Myriant Technologies LLC
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants
2. Myriant Technologies LLC Announces Appointment of Science Advisory Board Members
3. BioEnergy International, LLC Announces Formation of Myriant Technologies LLC
4. Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities
5. Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies
6. Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia
7. Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate
8. Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics
9. Promega and SwitchGear Publish Findings from Combined Technologies that Correlate Binding Events and Transcriptional Activity
10. Senesco Technologies, Inc. Announces Management Change
11. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2010 Results; Teleconference and Webcast to be held on November 16, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... -- A person commits a crime, and the detective uses ... criminal down. An outbreak of foodborne illness makes ... uses DNA evidence to track down the bacteria that caused ... not. The FDA has increasingly used a complex, cutting-edge technology ... Put as simply as possible, whole genome sequencing is a ...
(Date:6/23/2016)... ... 2016 , ... Charm Sciences, Inc. is pleased to announce ... Research Institute approval 061601. , “This is another AOAC-RI approval of the Peel ... President of Regulatory and Industrial Affairs. “The Peel Plate methods perform comparably to ...
(Date:6/23/2016)...  The Biodesign Challenge (BDC), a university competition that ... living systems and biotechnology, announced its winning teams at ... New York City . The teams, ... at MoMA,s Celeste Bartos Theater during the daylong summit. ... curator of architecture and design, and Suzanne Lee ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... announced the launch of the Supplyframe Design Lab . Located in Pasadena, ... explore the future of how hardware projects are designed, built and brought to ...
Breaking Biology Technology:
(Date:6/16/2016)... 16, 2016 The global ... to reach USD 1.83 billion by 2024, according ... Inc. Technological proliferation and increasing demand in commercial ... to drive the market growth.      ... The development of advanced multimodal techniques for biometric ...
(Date:6/3/2016)... Das DOTM (Department ... hat ein 44 Millionen $-Projekt ... einschließlich Personalisierung, Registrierung und IT-Infrastruktur, an Decatur ... Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte internationale Anbieter ... aber Decatur wurde als konformste und innovativste ...
(Date:5/24/2016)... IRVINE, Calif. , May 24, 2016 Ampronix facilitates superior patient care ... LMD3251MT  3D medical LCD display is the latest premium product recently added to ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):